Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. annual report 30.04.2008 Pfaeffikon SZ, 30 April 2008 --- The fiscal year ending 31 December 2007 delivered solid results for shaPE with the gross investment income on the private equity portfolio reaching CHF 50.3 million and the share price ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/heavy construction/industry/new product/shares/stock market Baar (euro adhoc) - Last week HPC Hamburg Consulting GmbH forwarded a new economic analysis on the plans for a container harbour in Izmir/Turkey to Tayfun Ports AS, as was already ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. electronics/industry/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Last Tuesday, 25th March 2008, Tunc Telekomünikasyon - the Turkish subsidiary of Tunc Holding AG - has ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. electronics/finances/industry/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Tunc Telekomünikasyon A.S., the Turkish subsidiary of Tunc Holding AG, has bid for operations on the GSM network of Saudia Telecom Company (STC, ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/electronics/finances/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Tunc Telekomünikasyon A.S., the Turkish subsidiary of Tunc Holding AG, announces the conclusion of an agreement with Motorola (Buyukdere cad. ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. electronics/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Due to the listing of Tunc Holding AG in the open market of Deutsche Börse Frankfurt/Main, the concern publishes the year 2006 financial figures of the subsidiaries. In 2006 the seven subsidiaries gained a total revenue ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. electronics/finances/industry/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Bronz Telekom, the Georgian subsidiary of Tunc Holding AG, has emitted an offer in the scope of a bid invitation to LLC Warid Telecom in Gerogia (36 ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. electronics/finances/industry/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Tunc Telekomünikasyon, the Turkish subsidiary of Swiss Tunc Holding AG, announces its participation at the bid invitation of Timeturns Telecom ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. electronics/finances/industry/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Berke MMC the subsidiary of Suisse Tunc Holding AG in Azerbaijan has renewed the contract with Azerfon for maintenance-failure operations of the existing GSM Nokia Siemens Networks. Only through this ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. finances/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Tunc Telekomünikasyon, the Turkish subsidiary of Tunc Holding AG, expands its business at GSM technology into Albania. On 31 January and on 05 February 2008 two contracts ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. finances/shares/stock market/technology/telecommunication Zürich (euro adhoc) - Tunc Telekomünikasyon A.S., one of Suisse Tunc Holding subsidiaries, has signed distributorship agreements related to renewable energy sources with China International ...
Indianapolis (ots/PRNewswire) - - Global contest seeks expressions of the triumphs and challenges of living with diabetes through art, essay, poetry, photography and music Eli Lilly and Company, the International Diabetes Federation (IDF), and the International Society for Pediatric and ...
Geneva (ots/PRNewswire) - Acrongenomics, Inc. (OTC: AGNM) is pleased to announce that they have acquired a 10.9% interest in Molecular Vision Limited, on a fully diluted basis. The cash consideration will be used by Molecular Vision for working capital and to further develop its technology. Molecular Vision is developing low cost easy-to-use credit-card sized devices for medical testing that will greatly extend ...
San Antonio, Texas (ots/PRNewswire) - - New Findings From a Second Pivotal Phase 3 Study Show Subjects Receiving Ustekinumab Every 12 weeks Maintained Improvement From Psoriasis Through One Year One-year data from the second double blind, placebo-controlled Phase 3 study PHOENIX 1 showed therapy with ...
Basel, Switzerland (ots/PRNewswire) - - Many More Patients Can Now Benefit From Oral Chemotherapy That Significantly Reduces Treatment Time Roche announced today that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic colorectal cancer in combination with any chemotherapy in all lines of ...
Abbott Park, Illinois (ots/PRNewswire) - - Improved Medical Benefit Rating Granted for XIENCE V from French Health Authority Abbott (NYSE: ABT) today announced that it has received reimbursement approval in France for its XIENCE(TM) V Everolimus Eluting Coronary Stent System, the first drug eluting stent to demonstrate clinical superiority over another drug ...
Maidenhead, England (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced today that the European Medicines Agency (EMEA) has validated the marketing authorisation application for Torisel(R) (temsirolimus) for treating relapsed and/or refractory mantle cell lymphoma (MCL), a rare type of non-Hodgkin's lymphoma (NHL) that accounts for ...
Abbott Park, Illinois (ots/PRNewswire) - - Lopinavir/ritonavir tablet is the first and only co-formulated protease inhibitor tablet approved for use in children with HIV Abbott (NYSE: ABT) announced today that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee ...
Paris (ots/PRNewswire) - Sanofi-aventis announced today that the anticoagulant Clexane(R) (enoxaparin sodium injection) has been approved for marketing in Japan by the Ministry of Health, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing orthopaedic surgery of the lower limbs such as total hip replacement, total knee replacement and hip fracture surgery. Venous ...
Basel, Switzerland (ots/PRNewswire) - - Avastin Receives Broad Label Extension in Europe for the Treatment of Patients With Metastatic Colorectal Cancer Roche announced today that the European Commission (EC) has given its approval for the significantly wider use of its anti-angiogenic agent Avastin (bevacizumab) in patients suffering from ...
European Influenza Surveillance Scheme (EISS)
Utrecht, The Netherlands and Stockholm, Sweden (ots/PRNewswire) - The 'flu' has arrived in Europe, according to the European Influenza Surveillance Scheme (EISS) and the European Centre for Disease Prevention and Control (ECDC). The two organisations confirm an upsurge in the number of laboratory confirmed cases of influenza in several European countries. As of this week, 13 European countries are reporting significant influenza activity (Austria, Bulgaria, France, ...
Mississauga, Canada (ots/PRNewswire) - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today announced that The Lancet, a world-leading medical journal, will publish an article entitled 'Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial' in its January 19th issue (Lancet 2008; 371: 228-36). The article describes the results from Vasogen's ...
Evry, France (ots/PRNewswire) - - Not for Distribution in the United States, Canada or Japan Novagali Pharma, an emerging ophthalmic pharmaceutical company announced today that the Company's Investigational New Drug Application (IND) to conduct a Phase I clinical trial of its Nova63035, an ophthalmic ...
London (ots/PRNewswire) - AstraZeneca (LSE: AZN) (NYSE: AZN) today announced the launch of a new clinical trial, SATURN, designed to measure the impact of CRESTOR(TM) (rosuvastatin) 40 mg and atorvastatin (Lipitor(R)) 80 mg on the progression of atherosclerosis in high risk patients. SATURN will compare ...
Basel, Switzerland (ots/PRNewswire) - Following an announcement from Schering-Plough, Roche today affirmed the value of PEGASYS(R) (peginterferon alfa-2a) in combination with COPEGUS(R) (Roche's brand of ribavirin) as the market-leading treatment for patients with hepatitis C. Despite clear biases in the design of the "IDEAL" study that potentially favoured patients taking PegIntron(TM) (peginterferon alfa-2b) regimens ...
Calgary, Canada (ots/PRNewswire) - - Resverlogix Sees Early Success and Expedites Phase 2 Plans TSX Exchange Symbol: RVX Resverlogix is pleased to announce preliminary data from the RVX-208 Phase 1 safety and pharmacokinetics study. Forty healthy volunteers have so far been treated of which sixteen have received multiple doses. As anticipated from the extensive Investigational New Drug toxicology studies no ...
Nairobi (ots/PRNewswire) - cbm through its staff and Regional Office in Nairobi is providing emergency assistance to the humanitarian crisis in Kenya. It is estimated that around 500,000 people have lost their homes, due to the widespread violence following the disputed election. Prof. Allen Foster, cbm's President announced, "There is an urgent need of food, shelter and health services, and cbm will ...
Baar, Switzerland (ots) - Manas Petroleum Corporation (MNAP.OB) is pleased to announce the results of a Resource Evaluation prepared by Gustavson Associates LLC regarding Manas Petroleum's blocks A, B,D and E in Albania. The Report considers the licenses 8 primary and recognized prospects identified from ...
Basel, Switzerland (ots/PRNewswire) - - For non US or non UK Media Only - Oral Chemotherapy Tablet Option Reduces the Time Patients Need to Spend in the Hospital Data recently published in the New England Journal of Medicine confirm oral chemotherapy tablet Xeloda (capecitabine) as a first-line ...
Toronto (ots/PRNewswire) - - President of cbm, Prof. Allen Foster Announces That cbm Has Expanded its Areas of Work to Include All Persons With Disability, Not Just Persons With Visual Loss. For the past 100 years, cbm previously known as Christoffel Blinden Mission, and Christian Blind Mission, has worked to prevent and treat blindness and provide education and rehabilitation services for persons with visual loss. "The organization has decided that its ...